Deborah Mason, NP
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Deborah Mason’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C19713 · Cancelled
Licence status: Cancelled · since 1958 · University of Wisconsin Medical School.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$24,100
Medicare paid this office $24,100 for 272 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 109 | $6,795 | $58 |
| New patient visit (30+ min) | 85 | $6,188 | $73 |
| Return visit (30+ min) | 37 | $4,092 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,271 | $134 |
| Long return visit (40+ min) | 11 | $1,749 | $146 |
See all 6 services
| Short return visit (20+ min) | 109 | $6,795 | $58 |
| New patient visit (30+ min) | 85 | $6,188 | $73 |
| Return visit (30+ min) | 37 | $4,092 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,271 | $134 |
| Long return visit (40+ min) | 11 | $1,749 | $146 |
| New patient visit (15+ min) | 15 | $663 | $44 |
Who their Medicare patients are
272 Original Medicare patients in 2024. Average age 78 · Women 64% · Also on Medicaid 9% · Health risk score 1.11. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 64% · Chronic kidney disease 21% · Coronary heart disease 19% · Diabetes 18% · Atrial fibrillation 18% · Cancer 17% · Depression 14% · Heart failure 12% · COPD 8% · Dementia 8% · Stroke 6%.
The office billed $98,682, Medicare allowed $34,710 and paid $24,100; for 326 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 272 | 326 | 78 | 1.11 | $98,682 | $24,100 |
| 2023 | 173 | 215 | 77 | 0.95 | $53,709 | $15,673 |
| 2022 | 179 | 201 | 75 | 0.83 | $49,175 | $16,518 |
| 2021 | 61 | 73 | 72 | 0.89 | $12,395 | $4,971 |
| 2020 | 156 | 181 | 74 | 0.98 | $26,820 | $12,001 |
| 2019 | 125 | 147 | 71 | 0.89 | $37,506 | $8,619 |
| 2018 | 135 | 182 | 70 | 0.86 | $47,023 | $10,383 |
| 2017 | 111 | 137 | 67 | 1.02 | $33,621 | $7,401 |
| 2016 | 34 | 50 | 73 | 0.88 | $4,974 | $2,459 |
| 2015 | 43 | 83 | 73 | 0.79 | $3,661 | $3,053 |
| 2014 | 62 | 126 | 77 | 0.71 | $3,392 | $3,245 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 69 | $4,455 | $63 |
| Return visit (30+ min) | 20 | $2,341 | $102 |
| New patient visit (30+ min) | 19 | $1,582 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,492 | $136 |
| Short return visit | 34 | $1,413 | $42 |
| New patient visit (15+ min) | 19 | $1,107 | $58 |
2022: 3 services
| Short return visit (20+ min) | 121 | $9,277 | $75 |
| Return visit (30+ min) | 26 | $3,090 | $114 |
| Short return visit | 17 | $870 | $51 |
2021: 2 services
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,245 | $66 |
| Short return visit (20+ min) | 13 | $997 | $77 |
2020: 5 services
| Telephone medical discussion with physician, 21-30 minutes | 43 | $4,253 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 54 | $3,616 | $67 |
| Return visit (30+ min) | 23 | $1,308 | $50 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $929 | $44 |
| Short return visit (20+ min) | 18 | $780 | $41 |
2019: 2 services
| Return visit (30+ min) | 62 | $5,290 | $79 |
| Short return visit (20+ min) | 58 | $2,533 | $42 |
2018: 2 services
| Return visit (30+ min) | 81 | $6,662 | $70 |
| Short return visit (20+ min) | 60 | $3,212 | $47 |
2017: 2 services
| Return visit (30+ min) | 53 | $4,377 | $74 |
| Short return visit (20+ min) | 60 | $2,907 | $43 |
2015: 2 services
| Influenza vaccine split virus, preservative free | 24 | $791 | $33 |
| Administration of influenza virus vaccine | 26 | $535 | $21 |
2014: 2 services
| Influenza vaccine split virus, preservative free | 52 | $1,579 | $30 |
| Administration of influenza virus vaccine | 59 | $1,214 | $21 |
Drugs they prescribed that Part D paid
$7,012
Pharmacies billed $7,012 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
270 generic and fewer than 11 brand-name prescriptions · $7,012 in drug cost · 62 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 13 | $301 | $23 |
| Levothyroxine | 23 | $264 | $11 |
| Cephalexin | 17 | $112 | $7 |
| Azithromycin | 17 | $90 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $90 | $8 |
See all 6 drugs
| Fluticasone Propionate | 13 | $301 | $23 |
| Levothyroxine | 23 | $264 | $11 |
| Cephalexin | 17 | $112 | $7 |
| Azithromycin | 17 | $90 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $90 | $8 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 310 | 170 | None | None | $7,012 |
| 2023 | 357 | 153 | 0% (0) | 6% | $10,073 |
| 2022 | 477 | 198 | None | 4% | $17,744 |
| 2021 | 247 | 105 | 11% (27) | 9% | $5,925 |
| 2020 | 278 | 107 | 8% (22) | None | $6,484 |
| 2019 | 504 | 199 | 14% (71) | 13% | $16,248 |
| 2018 | 541 | 208 | 23% (123) | None | $22,037 |
| 2017 | 137 | 81 | 13% (18) | 9% | $5,272 |
| 2016 | 14 | 12 | 0% (0) | None | $227 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Levothyroxine | 24 | $521 | $22 |
| Alendronate | 12 | $238 | $20 |
| Atorvastatin | 18 | $233 | $13 |
| Tamsulosin | 11 | $210 | $19 |
| Omeprazole | 18 | $149 | $8 |
| Azithromycin | 14 | $111 | $8 |
| Paxlovid (Eua) | 11 | $89 | $8 |
| Meloxicam | 12 | $89 | $7 |
2022: 8 drugs
| Levothyroxine | 48 | $728 | $15 |
| Paxlovid (Eua) | 24 | $250 | $10 |
| Atorvastatin | 19 | $218 | $11 |
| Trazodone | 18 | $185 | $10 |
| Losartan | 15 | $116 | $8 |
| Omeprazole | 13 | $109 | $8 |
| Amlodipine Besylate | 23 | $93 | $4 |
| Lisinopril-Hydrochlorothiazide | 11 | $48 | $4 |
2021: 6 drugs
| Levothyroxine | 47 | $692 | $15 |
| Hydrocodone-Acetaminophen | 18 | $604 | $34 |
| Atorvastatin | 11 | $178 | $16 |
| Trazodone | 15 | $155 | $10 |
| Amlodipine Besylate | 11 | $105 | $10 |
| Omeprazole | 11 | $83 | $8 |
2020: 6 drugs
| Levothyroxine | 46 | $739 | $16 |
| Hydrocodone-Acetaminophen | 17 | $226 | $13 |
| Trazodone | 12 | $195 | $16 |
| Omeprazole | 17 | $128 | $8 |
| Zolpidem | 14 | $119 | $9 |
| Sertraline | 13 | $22 | $2 |
2019: 9 drugs
| Hydrocodone-Acetaminophen | 44 | $1,246 | $28 |
| Levothyroxine | 39 | $494 | $13 |
| Atorvastatin | 16 | $300 | $19 |
| Zolpidem | 33 | $295 | $9 |
| Lorazepam | 23 | $213 | $9 |
| Clonazepam | 11 | $118 | $11 |
| Omeprazole | 18 | $73 | $4 |
| Azithromycin | 12 | $64 | $5 |
| Sertraline | 12 | $39 | $3 |
2018: 9 drugs
| Hydrocodone-Acetaminophen | 68 | $2,455 | $36 |
| Levothyroxine | 35 | $347 | $10 |
| Zolpidem | 34 | $309 | $9 |
| Lorazepam | 23 | $195 | $8 |
| Clonazepam | 11 | $123 | $11 |
| Omeprazole | 20 | $106 | $5 |
| Azithromycin | 15 | $104 | $7 |
| Sertraline | 16 | $91 | $6 |
| Tramadol | 13 | $89 | $7 |
2017: 2 drugs
| Hydrocodone-Acetaminophen | 11 | $182 | $17 |
| Gabapentin | 12 | $144 | $12 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | None | $20 |
| 2024 | 5 | 5 | None | $588 |
| 2023 | 3 | 4 | None | $467 |
| 2022 | 4 | 5 | None | $485 |
| 2021 | 1 | 1 | None | $102 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Octapharma USA | Balfaxar | $20 | 1 payment
|
See the published payment
| Octapharma USA | Meals · 2025-06-17 | Balfaxar | $20 |
See earlier years (2024, 2023, 2022, 2021)
2024: $588
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $122 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $122 | 1 payment
|
| Gilead Sciences | Epclusa | $122 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $87 | 1 payment
|
2023: $467
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $231 | 2 payments
|
| Gilead Sciences | Epclusa | $125 | 1 payment
|
| Abbvie | Vraylar | $111 | 1 payment
|
2022: $485
| Amgen | Avsola | $183 | 2 payments
|
| Otsuka Pharmaceutical Development & Commercialization | None | $134 | 1 payment
|
| Eisai | None | $108 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $60 | 1 payment
|
2021: $102
| Amgen | Repatha | $102 | 1 payment
|
Professional record
- NPI
- 1932404506
- Licence
- CA C#19713, CA RN 384656California C19713: Cancelled
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 163WP2201X (163WP2201X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2011-01-12
- NPI last updated
- 2016-11-09
This is when the NPI record was last certified, not a medical board exam.